Pages that link to "Q69005831"

The following pages link to Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications (Q69005831):

Displaying 17 items.

• Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties (Q33551688) (← links)
• Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury (Q34458652) (← links)
• Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses (Q36044109) (← links)
• Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1. (Q36363690) (← links)
• Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions (Q40517227) (← links)
• Antibody-directed enzyme prodrug therapy (Q40589853) (← links)
• Biodistribution of radiolabeled monoclonal antibody after intraperitoneal administration in nude mice with hepatic metastasis from human colon cancer (Q41647491) (← links)
• Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody (Q41810145) (← links)
• Plasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo (Q41936147) (← links)
• Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model (Q42283385) (← links)
• Blocked and not blocked whole-ricin-antibody immunotoxins: intraperitoneal therapy of human tumour xenografted in nude mice. (Q50120549) (← links)
• Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial (Q56574975) (← links)
• Biodistribution of neoglycoproteins in mice bearing solid Ehrlich tumor (Q67955875) (← links)
• Rapid background reduction of circulating sodium iodide I 125-labelled Pisum sativum agglutinin used as a tumor-imaging radiopharmaceutical by the chemically galactosylated antibody (Q68551059) (← links)
• Enhancement of clearance of plant lectins as radiopharmaceuticals by chemically glycosylated antilectin antibody (Q69720864) (← links)
• Binding parameters of monoclonal antibodies reacting with ovarian carcinoma ascites cells (Q69961973) (← links)
• Antibody-directed enzyme prodrug therapy (ADEPT). A three-phase study in ovarian tumor xenografts (Q72208052) (← links)